Taken together, our data implicate NRP1 as part of a biological pathway that affects the arterial macrophage cytoskeleton and becomes altered in response to early intermittent hyperlipidaemia, leading to acceleration of atherosclerosis. The gene discussed is NRP1; the disease is atherosclerosis.